LUPIN.NS - Lupin Limited

NSE - NSE Real Time Price. Currency in INR

Lupin Limited

Laxmi Towers, B Wing
5th Floor Bandra Kurla Complex Bandra (East)
Mumbai 400051
India
91 22 6640 2222
http://www.lupin.com

SectorHealthcare
IndustryDrugs - Generic
Full Time Employees16,792

Key Executives

NameTitlePayExercisedYear Born
Mrs. Manju Deshbandhu GuptaChairman5.1MN/A1944
Ms. Vinita D. GuptaCEO & Exec. Director173.73MN/A1968
Mr. Nilesh D. GuptaMD & Exec. Director81.78MN/AN/A
Mr. Ramesh SwaminathanCFO & Exec. Director43.75MN/AN/A
Mr. Rajvardhan V. SatamCompany Sec.6.4MN/AN/A
Amounts are as of December 31, 2017 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in INR.

Description

Lupin Limited, a pharmaceutical company, develops, produces, and markets a range of branded and generic formulations, biotechnology products, and active pharmaceutical ingredients (APIs) worldwide. It offers formulations for use in the therapeutic areas of cardiovascular, diabetology, asthama, pediatrics, central nervous system (CNS), gastro-intestinal, anti-infectives, nonsteroidal anti inflammatory drug therapy, anti-TB, and cephalosporins. The company also develops drug delivery technologies; and offers biosimilars for various therapies, such as oncology, anti-inflammatory, anti-virals, rheumatoid arthritis, endocrinology, diabetes, ophthalmology, and women's health. In addition, it engages in the novel drug discovery and development programs for use in the treatment of CNS disorders, oncology, immunology, pain, and metabolic disorders. The company was formerly known as Lupin Chemicals Limited and changed its name to Lupin Limited in 2001 as a result of its amalgamation with Lupin Laboratories Limited. Lupin Limited was founded in 1968 and is based in Mumbai, India.

Corporate Governance

Lupin Limited’s ISS Governance QualityScore as of April 1, 2018 is 4. The pillar scores are Audit: 1; Board: 4; Shareholder Rights: 1; Compensation: 8.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.